CLDX: Celldex Therapeutics Inc

22.08 USD 0.30 (1.34%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do CLDX para hoje mudou para -1.34%. Paralelamente, o preço mais baixo no mercado atingiu 21.71 e o mais alto foi 23.02.

Veja a dinâmica do par de moedas Celldex Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

CLDX Notícias

19:45 Celldex: Despite Dropping Eosinophilic Esophagitis Program, Barzolvolimab On Track (CLDX)
14:22 Why Is Celldex Therapeutics Stock Falling Today - Celldex Therapeutics (NASDAQ:CLDX)
12:27 La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Celldex Therapeutics (NASDAQ:CLDX), Alcon (NYSE:ALC)
11:44 Stifel reiterates Buy rating on Celldex stock despite EoE setback
11:28 H.C. Wainwright reiterates Buy rating on Eupraxia Pharmaceuticals stock
11:24 Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Color Star Tech (NASDAQ:ADD), Aspen Insurance Hldgs (NYSE:AHL)
11:14 Celldex stock price target lowered to $62 at Canaccord on EoE program halt
10:52 Celldex stock price target lowered to $42 by H.C. Wainwright
10:46 Celldex stock falls as Wells Fargo cuts price target on EOE trial failure
20:05 Celldex’s mast cell therapy fails to improve eosinophilic esophagitis
21:55 Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
20:22 Celldex Therapeutics earnings beat by $0.01, revenue fell short of estimates
12:13 scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
09:11 Jasper Therapeutics stock holds Market Outperform rating at JMP despite setback
11:27 Celldex stock price target maintained at $50 by H.C. Wainwright
15:00 Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
16:58 Crude Oil Rises 6%; US Consumer Sentiment Surges In June - Senmiao Tech (NASDAQ:AIHS), Chanson International (NASDAQ:CHSN)
14:33 Celldex shares jump on impressive skin disorder drug data
14:32 Visa, Mastercard lead Friday’s market cap stock movers
14:11 Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday - Bunge Global (NYSE:BG), AleAnna (NASDAQ:ANNA)
11:56 Celldex stock maintains Overweight rating on promising CSU therapy results
22:12 Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025
11:34 Celldex stock rating reiterated at Buy by Canaccord ahead of data release
20:12 Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress

Faixa diária

21.71 23.02

Faixa anual

14.40 46.90

Fechamento anterior: 22.38
Open: 22.52

Bid: 22.08
Ask: 22.38

Low: 21.71
High: 23.02

Volume: 2.143 K

Mudança diária: -1.34%
Mudança mensal: 1.24%

Mudança de 6 meses: 3.81%
Mudança anual: -45.82%

30 agosto, sábado